YMFCF yields 2.10% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, YMFCF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YMFCF + MRK for your $10,000?
Yamashin-Filter Corp. operates as a filter manufacturer. The company manufactures, develops, and sells filters for construction and agricultural machines, drive-train, fuel systems and various filter products for industrial and precision machines, and industrial filter related parts; and nano filter products. Its construction machinery filters include hydraulic fluid filters to protect hydraulic cylinders, controls, and hydraulic systems used on machinery; engine oil filters that are used in various types of engines to remove contaminants from oil; fuel filters used to construction machinery to remove contaminants and water from diesel fuel; transmission filters for on-highway/off-highway applications; industrial filters to filter hydraulic fluid, lubricating oil, and other liquids in a range of industrial machinery; and process filters, which are used for filtration and separation in manufacturing processes across a range of industries, including electronic parts, precision components, LCD displays, and food products. The company also provides various types of air filters for a range of settings, such as office buildings, factories, machines, and vehicles; and medical-grade masks and replacement inner sheets that are made using YAMASHIN NANO FILTER. It operates in Japan, Asia, North America, and Europe. The company was formerly known as Yamashin Industry Inc. and changed its name to Yamashin-Filter Corp. in October 2005. Yamashin-Filter Corp. was incorporated in 1956 and is headquartered in Yokohama, Japan.
Full YMFCF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.